Different anti-remodeling effect of nilotinib and fluticasone in a chronic asthma model

BACKGROUND/AIMS: Inhaled corticosteroids are the most effective treatment currently available for asthma, but their beneficial effect against airway remodeling is limited. The tyrosine kinase inhibitor nilotinib has inhibitory activity against c-kit and the platelet-derived growth factor receptor. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hye Seon, Rhee, Chin Kook, Lee, Hea Yon, Yoon, Hyoung Kyu, Kwon, Soon Seok, Lee, Sook Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094918/
https://www.ncbi.nlm.nih.gov/pubmed/27764539
http://dx.doi.org/10.3904/kjim.2015.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094918/
https://www.ncbi.nlm.nih.gov/pubmed/27764539
http://dx.doi.org/10.3904/kjim.2015.002

Ejemplares similares